Quest Diagnostics Increases Dividend, Announces Share Buyback

The company raises quarterly dividend by 7.5% and boosts share repurchase authorization by $1 billion.

Published on Feb. 10, 2026

Got story updates? Submit your updates here. ›

Quest Diagnostics, a leading provider of diagnostic information services, announced that its Board of Directors has authorized a 7.5% increase in its quarterly cash dividend to $0.86 per share. The company also increased its share repurchase authorization by $1 billion.

Why it matters

The dividend increase marks 15 consecutive years of dividend growth for Quest Diagnostics, demonstrating the company's financial strength and commitment to returning capital to shareholders. The expanded share buyback program also signals the company's confidence in its long-term prospects.

The details

The dividend increase will be effective with the dividend payable on April 20, 2026 to shareholders of record on April 6, 2026. The annual cash dividend will now be $3.44 per share. The company also increased its share repurchase authorization by $1 billion, in addition to the approximately $0.4 billion that was available as of December 31, 2025 under the existing program.

The dividend increase will be effective with the dividend payable on April 20, 2026.
Shareholders of record will be on April 6, 2026.

The players